Lightbox
Bronze Award
Friedreich's Back
Biogen
United States
2026
Share:
Facebook Linkedin X WhatsApp

Execution Video
Execution Video
Execution Video
Execution Video
Execution Video
Execution Video
Execution Video
Execution Video
Supporting Image
Supporting Image
Supporting Image
Supporting Image
Supporting Image
Supporting Image

To see entry media, create an account or log in.
Logging in grants access to Advanced Search
and more Entry Details.

Entrant Company
21Grams
Entry Type
Direct-to-Consumer: Branded
Launch Country
United States
Program
Clio Health 2026
Program
Traditional Mediums
Advertiser Category
Pharmaceutical
Medium
Creative Effectiveness
Category
National
SKYCLARYS was the first advancement in Friedreich ataxia (FA) since its discovery in 1863 by Nikolaus Friedreich, but the news wasn’t convincing patients to try it. They needed to hear it from an FA expert, but they didn’t trust their doctors. So, we resurrected the guy who discovered the disease. Knowing patients lean on dark humor and social media to cope with FA and connect with others, we created a dark comedy social media series that highlights the benefits of SKYCLARYS. We gave the audience the disease expert they were looking for in Nik, helping patients come together and make informed treatment decisions—through laughter.
Credits

To see entry credits, create an account or log in.
Logging in grants access to Advanced Search and more Entry Details.

Duplicate statues available now
Buy a Statue in Creative Effectiveness to Celebrate Your Team

Ads of the World